Won Ki-Bum, Han Donghee, Choi Su-Yeon, Chun Eun Ju, Park Sung Hak, Han Hae-Won, Sung Jidong, Jung Hae Ok, Chang Hyuk-Jae
Division of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei-Cedars-Sinai Integrative Cardiovascular Imaging Research Center, Yonsei University College of Medicine, Yonsei University Health System, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, South Korea.
Eur Heart J Open. 2021 Aug 11;1(1):oeab009. doi: 10.1093/ehjopen/oeab009. eCollection 2021 Aug.
Coronary artery calcium score (CACS) is widely used for cardiovascular risk stratification in asymptomatic population. We assessed the association of new blood pressure (BP) classification using the 2017 American College of Cardiology/American Heart Association guidelines with coronary artery calcification (CAC) progression according to age in asymptomatic adults.
Overall, 10 839 asymptomatic Korean adults (23.4% aged ≤45 years) who underwent at least two CACS evaluations for health check-up were enrolled. Participants were categorized by age (≤45 and >45 years) and BP [normal (<120/<80 mmHg, untreated), elevated (120-129/<80 mmHg, untreated), Stage 1 hypertension (untreated BP 130-139/80-89 mmHg) or Stage 2 hypertension (BP ≥140/≥90 mmHg or anti-hypertensive use)] groups. CAC progression was defined as a difference of ≥2.5 between the square root (√) of the baseline and follow-up CACS. During a mean 3.3-year follow-up, the incidence of CAC progression was 13.5% and 36.3% in individuals aged ≤45 and >45 years, respectively. After adjustment for age, sex, diabetes, dyslipidaemia, obesity, current smoking, and baseline CACS, hazard ratios (95% confidence interval) for CAC progression in elevated BP, Stage 1 hypertension, and Stage 2 hypertension compared to normal BP were 1.43 (0.96-2.14) ( = 0.077), 1.64 (1.20-2.23) ( = 0.002), and 2.38 (1.82-3.12) ( < 0.001) in the ≤45 years group and 1.11 (0.95-1.30) ( = 0.179), 1.17 (1.04-1.32) ( = 0.009), and 1.52 (1.39-1.66) ( < 0.001) in the >45 years group, respectively.
Newly defined Stage 1 hypertension is independently associated with CAC progression in asymptomatic adults regardless of age.
冠状动脉钙化评分(CACS)广泛用于无症状人群的心血管风险分层。我们根据2017年美国心脏病学会/美国心脏协会指南评估了新的血压分类与无症状成年人冠状动脉钙化(CAC)进展随年龄的关联。
总体而言,纳入了10839名接受至少两次CACS评估以进行健康检查的无症状韩国成年人(23.4%年龄≤45岁)。参与者按年龄(≤45岁和>45岁)和血压[正常(<120/<80 mmHg,未治疗)、血压升高(120 - 129/<80 mmHg,未治疗)、1级高血压(未治疗血压130 - 139/80 - 89 mmHg)或2级高血压(血压≥140/≥90 mmHg或使用抗高血压药物)]分组。CAC进展定义为基线和随访CACS的平方根(√)之差≥2.5。在平均3.3年的随访期间,年龄≤45岁和>45岁个体的CAC进展发生率分别为13.5%和36.3%。在调整年龄、性别、糖尿病、血脂异常、肥胖、当前吸烟和基线CACS后,与正常血压相比,血压升高、1级高血压和2级高血压组中≤45岁组的CAC进展风险比(95%置信区间)分别为1.43(0.96 - 2.14)(P = 0.077)、1.64(1.20 - 2.23)(P = 0.002)和2.38(1.82 - 3.12)(P < 0.001),>45岁组分别为1.11(0.95 - 1.30)(P = 0.179)、1.17(1.04 - 1.32)(P = 0.009)和1.52(1.39 - 1.66)(P < 0.001)。
新定义的1级高血压与无症状成年人的CAC进展独立相关,与年龄无关。